Researchclopedia
Research
Researchers
Institutions
Topics
Submit
About
Search...
⌘
K
Command Palette
Search for a command to run...
Back to research
Olomorasib+Pembrolizumab in KRAS G12C-Mutant NSCLC: Results from LOXO-RAS-20001 and SUNRAY-01
2026
0 citations
Journal Article
Field-Weighted Citation Impact:
0.00
Aristotle University of Thessaloniki
Jaromı́r Roubec
·
Vítkovická Nemocnice
N Reinmuth
·
Asklepios Fachkliniken München-Gauting
A Sacher
·
University Health Network
A Spira
·
Virginia Cancer Specialists
N Singhal
·
Centre for Cancer Biology
S Takeuchi
·
Kanazawa University Hospital
Yonina R. Murciano‐Goroff
·
Memorial Sloan Kettering Cancer Center
Y Zhou
·
Eli Lilly (United States)
A Fink
·
Eli Lilly (United States)
Nicolas Fasnacht
·
Eli Lilly (United States)
M Willard
·
Eli Lilly (United States)
Carla Visseren‐Grul
·
Eli Lilly (United States)
S Peters
·
University Hospital of Lausanne
Claas Wesseler
·
Asklepios Klinikum Harburg
Olomorasib+Pembrolizumab in KRAS G12C-Mutant NSCLC: Results from LOXO-RAS-20001 and SUNRAY-01 | Researchclopedia